Côte d'Ivoire vs North Macedonia: Treatment success rate for patients treated for MDR-TB
Côte d'Ivoire
75.0%
in 2022
North Macedonia
75.0%
in 2022
Côte d'Ivoire rank
70th
North Macedonia rank
70th
Treatment success rate for patients treated for MDR-TB over time
- Côte d'Ivoire
- North Macedonia
How they compare
Côte d'Ivoire currently reports 75.0% against 75.0% in North Macedonia, a difference of 0.0%.
The two have swapped places 4 times across 12 shared years of data; in 2003 it was North Macedonia ahead.
Côte d'Ivoire ranks 70th and North Macedonia ranks 70th of 163 countries.
Across the 3 decades both report, Côte d'Ivoire averaged higher in 2 and North Macedonia in 1.
Head to head by decade
| Decade | Côte d'Ivoire | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 17.5% | 66.5% | 49.0% | North Macedonia |
| 2010s | 77.4% | 31.9% | 45.6% | Côte d'Ivoire |
| 2020s | 76.0% | 58.3% | 17.7% | Côte d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Côte d'Ivoire or North Macedonia?
- Côte d'Ivoire, at 75.0% against 75.0% in North Macedonia as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Côte d'Ivoire and North Macedonia?
- 0.0%, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and North Macedonia?
- 12 years are reported by both, from 2003 to 2022.
- How do Côte d'Ivoire and North Macedonia rank globally for treatment success rate for patients treated for mdr-tb?
- Côte d'Ivoire ranks 70th and North Macedonia ranks 70th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.